MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2026 International Congress

    Interplay of sex and GBA1 and LRRK2 genotype in Parkinson disease progression

    J. Park, M. Yang, N. Masood, R. Ortega, D. Raymond, A. Wise, B. Green, K. Leaver, V. Katsnelson, V. Shanker, M. Swan, M. Pullman, A. Domingo, L. Ozelius, S. Bressman, C. Wang, R. Saunders-Pullman (New York, USA)

    Objective: To characterize disease heterogeneity and how sex impacts motor and cognitive progression class membership across genetic subgroups of GBA1, LRRK2, and idiopathic Parkinson disease (PD). Background: Autosomal…
  • 2026 International Congress

    Efficacy of Repetitive Transcranial Magnetic Stimulation for Improving Motor Function in Parkinson’s disease; A Prospective, Multicenter, Crossover Study

    SJ. Lee, HA. Kim, JE. Kim, MS. Shin, DY. Kown, HW. Shin (Seoul, Republic of Korea)

    Objective: We aimed to investigate the effect of repetitive transcranial magnetic stimulation (rTMS) on the improvement of motor function in patients with Parkinson’s disease (PD).…
  • 2026 International Congress

    Long-term evolution of deep brain stimulation parameters in Parkinson´s Disease: A 6-year analysis.

    D. Oropeza-Velázquez, A. Morales-Velez, LA. Haro-Santillan, M. Velázquez-Vaquero, D. Oropeza-Canto, E. Peña-Andrade, Y. Tiburcio-Núñez, D. Blumenkron-Marroquín, A. Romero-Pérez, CE. Chávez-Donis (Puebla, Mexico)

    Objective: Characterize longitudinal evolution of Deep Brain Stimulation (DBS) parameters in patients with Parkinson´s Disease (PD) over a 6-year period and evaluate stability of programming…
  • 2026 International Congress

    Real-World Experience with Continuous Subcutaneous Foslevodopa/Foscarbidopa (FLC/FCD) in Advanced Parkinson’s Disease: A Single-Centre Cohort Study

    K. Waqar, M. Thomas, Y. Abdelmajid, E. Freitas, R. Cabrito, RH. Battah, A. Anjum, SH. Mittal (Abu Dhabi, United Arab Emirates)

    Objective: To evaluate efficacy, safety, and discontinuation rates of FLC/FCD in a retrospective cohort of advanced PD patients. Background: Continuous subcutaneous FLC/FCD is a novel…
  • 2026 International Congress

    Modulated functional connectivity in patients with Parkinson’s disease by transcutaneous auricular acupoint Vagus Nerve Stimulation (taVNS)

    XJ. Dan, SS. Gao, JL. Fang, P. Chan (45#Changchun Street, Xicheng District, Beijing, China)

    Objective: To explore the brain function mechanism of rs-fMRI in the treatment of PD by taVNS. Background: TaVNS has the potential  to improve the clinical…
  • 2026 International Congress

    Effects of Repetitive Deep TMS on Motor Function and Cerebral Perfusion in Parkinson’s Disease

    B. Kim, M. Chang, I. Song (Seoul, Republic of Korea)

    Objective: This study aimed to investigate the effects of deep repetitive transcranial magnetic stimulation (dTMS) using an H-coil on cerebral perfusion and motor function in…
  • 2026 International Congress

    Exercise and SUTT: A 9-week randomized, double-blinded, controlled intervention on Parkinsonian Gait.

    E. Atterbury, J. Watson-van Zyl, K. Welman (Cape Town, South Africa)

    Objective: To determine the effect of exercise combined with self-initiated unclassified therapeutic tremors (SUTT), over 9 weeks, compared to exercise-alone, on gait in people with…
  • 2026 International Congress

    Dual-Task Gait Costs do not Increase Across Stages of Parkinson’s Disease

    H. Bernini, G. Koitla, V. Silva, L. Santos, L. Aranha, D. Garcia, M. Santos, G. Santos, P. Silva, M. Piemonte (São Paulo, Brazil)

    Objective: To investigate whether motor and cognitive dual-task (DT) gait costs differ between early and intermediate stages of Parkinson’s disease (PD). Background: In PD, reduced…
  • 2026 International Congress

    Disentangling Disease- and Medication-Associated Gut Microbiome Signatures in Parkinson’s Disease

    MG. Choi, SY. Jo, JY. Lee, HN. Im, GY. Lee, SJ. Chung (Seoul, Republic of Korea)

    Objective: To determine how Parkinson’s disease (PD) medications influence gut microbiome composition and function, and to distinguish microbiome features associated with PD pathology from those…
  • 2026 International Congress

    Regional α-Synuclein Seeding Activity in Parkinson’s disease and Multiple System Atrophy

    D. Kim, D. Yoo, S. An, M. Kang, T. Ahn (Seoul, Republic of Korea)

    Objective: This study aimed to profile regional α‑synuclein (α-syn) seeding activity in postmortem brains from Parkinson’s disease (PD) and multiple system atrophy (MSA) and to…
  • « Previous Page
  • 1
  • …
  • 100
  • 101
  • 102
  • 103
  • 104
  • …
  • 553
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley